story of the week
Darolutamide in Metastatic and Hormone-Sensitive Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer
N. Engl. J. Med 2022 Feb 17;[EPub Ahead of Print], MR Smith, M Hussain, F Saad, K Fizazi, CN Sternberg, ED Crawford, E Kopyltsov, CH Park, B Alekseev, Á Montesa-Pino, D Ye, F Parnis, F Cruz, TLJ Tammela, H Suzuki, T Utriainen, C Fu, M Uemura, MJ Méndez-Vidal, BL Maughan, H Joensuu, S Thiele, R Li, I Kuss, B TombalFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.